Global Melanoma Skin Cancer Diagnostic Testing Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Melanoma Skin Cancer Diagnostic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Melanoma Skin Cancer Diagnostic Testing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Melanoma Skin Cancer Diagnostic Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Biopsy segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Melanoma Skin Cancer Diagnostic Testing include Myriad Genetics, Abbott Laboratories, Foundation Medicine, Pathway Genomics Corporation, and Cancer Genetics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Melanoma Skin Cancer Diagnostic Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Melanoma Skin Cancer Diagnostic Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Melanoma Skin Cancer Diagnostic Testing, with revenue, gross margin and global market share of Melanoma Skin Cancer Diagnostic Testing from 2019 to 2022.
Chapter 3, the Melanoma Skin Cancer Diagnostic Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Melanoma Skin Cancer Diagnostic Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Melanoma Skin Cancer Diagnostic Testing research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Melanoma Skin Cancer Diagnostic Testing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Melanoma Skin Cancer Diagnostic Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Biopsy segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Melanoma Skin Cancer Diagnostic Testing include Myriad Genetics, Abbott Laboratories, Foundation Medicine, Pathway Genomics Corporation, and Cancer Genetics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Melanoma Skin Cancer Diagnostic Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Biopsy
- Imaging
- Others
- Hospitals
- Dermatology Clinics
- Diagnostic Laboratories
- Others
- Myriad Genetics
- Abbott Laboratories
- Foundation Medicine
- Pathway Genomics Corporation
- Cancer Genetics
- Castle Biosciences
- NeoGenomics
- Dermtech
- Sysmex Inostics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Melanoma Skin Cancer Diagnostic Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Melanoma Skin Cancer Diagnostic Testing, with revenue, gross margin and global market share of Melanoma Skin Cancer Diagnostic Testing from 2019 to 2022.
Chapter 3, the Melanoma Skin Cancer Diagnostic Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Melanoma Skin Cancer Diagnostic Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Melanoma Skin Cancer Diagnostic Testing research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Melanoma Skin Cancer Diagnostic Testing
1.2 Classification of Melanoma Skin Cancer Diagnostic Testing by Type
1.2.1 Overview: Global Melanoma Skin Cancer Diagnostic Testing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Type in 2021
1.2.3 Biopsy
1.2.4 Imaging
1.2.5 Others
1.3 Global Melanoma Skin Cancer Diagnostic Testing Market by Application
1.3.1 Overview: Global Melanoma Skin Cancer Diagnostic Testing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Dermatology Clinics
1.3.4 Diagnostic Laboratories
1.3.5 Others
1.4 Global Melanoma Skin Cancer Diagnostic Testing Market Size & Forecast
1.5 Global Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast by Region
1.5.1 Global Melanoma Skin Cancer Diagnostic Testing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Melanoma Skin Cancer Diagnostic Testing Market Size by Region, (2017-2022)
1.5.3 North America Melanoma Skin Cancer Diagnostic Testing Market Size and Prospect (2017-2028)
1.5.4 Europe Melanoma Skin Cancer Diagnostic Testing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Size and Prospect (2017-2028)
1.5.6 South America Melanoma Skin Cancer Diagnostic Testing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Melanoma Skin Cancer Diagnostic Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Melanoma Skin Cancer Diagnostic Testing Market Drivers
1.6.2 Melanoma Skin Cancer Diagnostic Testing Market Restraints
1.6.3 Melanoma Skin Cancer Diagnostic Testing Trends Analysis
2 COMPANY PROFILES
2.1 Myriad Genetics
2.1.1 Myriad Genetics Details
2.1.2 Myriad Genetics Major Business
2.1.3 Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Product and Solutions
2.1.4 Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Myriad Genetics Recent Developments and Future Plans
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Product and Solutions
2.2.4 Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Abbott Laboratories Recent Developments and Future Plans
2.3 Foundation Medicine
2.3.1 Foundation Medicine Details
2.3.2 Foundation Medicine Major Business
2.3.3 Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Product and Solutions
2.3.4 Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Foundation Medicine Recent Developments and Future Plans
2.4 Pathway Genomics Corporation
2.4.1 Pathway Genomics Corporation Details
2.4.2 Pathway Genomics Corporation Major Business
2.4.3 Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Product and Solutions
2.4.4 Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Pathway Genomics Corporation Recent Developments and Future Plans
2.5 Cancer Genetics
2.5.1 Cancer Genetics Details
2.5.2 Cancer Genetics Major Business
2.5.3 Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Product and Solutions
2.5.4 Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Cancer Genetics Recent Developments and Future Plans
2.6 Castle Biosciences
2.6.1 Castle Biosciences Details
2.6.2 Castle Biosciences Major Business
2.6.3 Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Product and Solutions
2.6.4 Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Castle Biosciences Recent Developments and Future Plans
2.7 NeoGenomics
2.7.1 NeoGenomics Details
2.7.2 NeoGenomics Major Business
2.7.3 NeoGenomics Melanoma Skin Cancer Diagnostic Testing Product and Solutions
2.7.4 NeoGenomics Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 NeoGenomics Recent Developments and Future Plans
2.8 Dermtech
2.8.1 Dermtech Details
2.8.2 Dermtech Major Business
2.8.3 Dermtech Melanoma Skin Cancer Diagnostic Testing Product and Solutions
2.8.4 Dermtech Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Dermtech Recent Developments and Future Plans
2.9 Sysmex Inostics
2.9.1 Sysmex Inostics Details
2.9.2 Sysmex Inostics Major Business
2.9.3 Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Product and Solutions
2.9.4 Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Sysmex Inostics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Melanoma Skin Cancer Diagnostic Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Melanoma Skin Cancer Diagnostic Testing Players Market Share in 2021
3.2.2 Top 10 Melanoma Skin Cancer Diagnostic Testing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Melanoma Skin Cancer Diagnostic Testing Players Head Office, Products and Services Provided
3.4 Melanoma Skin Cancer Diagnostic Testing Mergers & Acquisitions
3.5 Melanoma Skin Cancer Diagnostic Testing New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Melanoma Skin Cancer Diagnostic Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Melanoma Skin Cancer Diagnostic Testing Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Application (2017-2022)
5.2 Global Melanoma Skin Cancer Diagnostic Testing Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2028)
6.2 North America Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2028)
6.3 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country
6.3.1 North America Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2017-2028)
6.3.2 United States Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
6.3.3 Canada Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
6.3.4 Mexico Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2028)
7.2 Europe Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2028)
7.3 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country
7.3.1 Europe Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2017-2028)
7.3.2 Germany Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
7.3.3 France Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
7.3.5 Russia Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
7.3.6 Italy Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Size by Region
8.3.1 Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue by Region (2017-2028)
8.3.2 China Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
8.3.3 Japan Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
8.3.4 South Korea Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
8.3.5 India Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
8.3.7 Australia Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2028)
9.2 South America Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2028)
9.3 South America Melanoma Skin Cancer Diagnostic Testing Market Size by Country
9.3.1 South America Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2017-2028)
9.3.2 Brazil Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
9.3.3 Argentina Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size by Country
10.3.1 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2017-2028)
10.3.2 Turkey Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
10.3.4 UAE Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Melanoma Skin Cancer Diagnostic Testing
1.2 Classification of Melanoma Skin Cancer Diagnostic Testing by Type
1.2.1 Overview: Global Melanoma Skin Cancer Diagnostic Testing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Type in 2021
1.2.3 Biopsy
1.2.4 Imaging
1.2.5 Others
1.3 Global Melanoma Skin Cancer Diagnostic Testing Market by Application
1.3.1 Overview: Global Melanoma Skin Cancer Diagnostic Testing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Dermatology Clinics
1.3.4 Diagnostic Laboratories
1.3.5 Others
1.4 Global Melanoma Skin Cancer Diagnostic Testing Market Size & Forecast
1.5 Global Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast by Region
1.5.1 Global Melanoma Skin Cancer Diagnostic Testing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Melanoma Skin Cancer Diagnostic Testing Market Size by Region, (2017-2022)
1.5.3 North America Melanoma Skin Cancer Diagnostic Testing Market Size and Prospect (2017-2028)
1.5.4 Europe Melanoma Skin Cancer Diagnostic Testing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Size and Prospect (2017-2028)
1.5.6 South America Melanoma Skin Cancer Diagnostic Testing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Melanoma Skin Cancer Diagnostic Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Melanoma Skin Cancer Diagnostic Testing Market Drivers
1.6.2 Melanoma Skin Cancer Diagnostic Testing Market Restraints
1.6.3 Melanoma Skin Cancer Diagnostic Testing Trends Analysis
2 COMPANY PROFILES
2.1 Myriad Genetics
2.1.1 Myriad Genetics Details
2.1.2 Myriad Genetics Major Business
2.1.3 Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Product and Solutions
2.1.4 Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Myriad Genetics Recent Developments and Future Plans
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Product and Solutions
2.2.4 Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Abbott Laboratories Recent Developments and Future Plans
2.3 Foundation Medicine
2.3.1 Foundation Medicine Details
2.3.2 Foundation Medicine Major Business
2.3.3 Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Product and Solutions
2.3.4 Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Foundation Medicine Recent Developments and Future Plans
2.4 Pathway Genomics Corporation
2.4.1 Pathway Genomics Corporation Details
2.4.2 Pathway Genomics Corporation Major Business
2.4.3 Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Product and Solutions
2.4.4 Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Pathway Genomics Corporation Recent Developments and Future Plans
2.5 Cancer Genetics
2.5.1 Cancer Genetics Details
2.5.2 Cancer Genetics Major Business
2.5.3 Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Product and Solutions
2.5.4 Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Cancer Genetics Recent Developments and Future Plans
2.6 Castle Biosciences
2.6.1 Castle Biosciences Details
2.6.2 Castle Biosciences Major Business
2.6.3 Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Product and Solutions
2.6.4 Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Castle Biosciences Recent Developments and Future Plans
2.7 NeoGenomics
2.7.1 NeoGenomics Details
2.7.2 NeoGenomics Major Business
2.7.3 NeoGenomics Melanoma Skin Cancer Diagnostic Testing Product and Solutions
2.7.4 NeoGenomics Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 NeoGenomics Recent Developments and Future Plans
2.8 Dermtech
2.8.1 Dermtech Details
2.8.2 Dermtech Major Business
2.8.3 Dermtech Melanoma Skin Cancer Diagnostic Testing Product and Solutions
2.8.4 Dermtech Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Dermtech Recent Developments and Future Plans
2.9 Sysmex Inostics
2.9.1 Sysmex Inostics Details
2.9.2 Sysmex Inostics Major Business
2.9.3 Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Product and Solutions
2.9.4 Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Sysmex Inostics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Melanoma Skin Cancer Diagnostic Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Melanoma Skin Cancer Diagnostic Testing Players Market Share in 2021
3.2.2 Top 10 Melanoma Skin Cancer Diagnostic Testing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Melanoma Skin Cancer Diagnostic Testing Players Head Office, Products and Services Provided
3.4 Melanoma Skin Cancer Diagnostic Testing Mergers & Acquisitions
3.5 Melanoma Skin Cancer Diagnostic Testing New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Melanoma Skin Cancer Diagnostic Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Melanoma Skin Cancer Diagnostic Testing Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Application (2017-2022)
5.2 Global Melanoma Skin Cancer Diagnostic Testing Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2028)
6.2 North America Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2028)
6.3 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country
6.3.1 North America Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2017-2028)
6.3.2 United States Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
6.3.3 Canada Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
6.3.4 Mexico Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2028)
7.2 Europe Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2028)
7.3 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country
7.3.1 Europe Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2017-2028)
7.3.2 Germany Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
7.3.3 France Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
7.3.5 Russia Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
7.3.6 Italy Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Size by Region
8.3.1 Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue by Region (2017-2028)
8.3.2 China Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
8.3.3 Japan Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
8.3.4 South Korea Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
8.3.5 India Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
8.3.7 Australia Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2028)
9.2 South America Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2028)
9.3 South America Melanoma Skin Cancer Diagnostic Testing Market Size by Country
9.3.1 South America Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2017-2028)
9.3.2 Brazil Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
9.3.3 Argentina Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size by Country
10.3.1 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2017-2028)
10.3.2 Turkey Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
10.3.4 UAE Melanoma Skin Cancer Diagnostic Testing Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global Melanoma Skin Cancer Diagnostic Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Melanoma Skin Cancer Diagnostic Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Melanoma Skin Cancer Diagnostic Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Region (2023-2028)
Table 6. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 7. Myriad Genetics Major Business
Table 8. Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Product and Solutions
Table 9. Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Product and Solutions
Table 13. Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Foundation Medicine Corporate Information, Head Office, and Major Competitors
Table 15. Foundation Medicine Major Business
Table 16. Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Product and Solutions
Table 17. Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Pathway Genomics Corporation Corporate Information, Head Office, and Major Competitors
Table 19. Pathway Genomics Corporation Major Business
Table 20. Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Product and Solutions
Table 21. Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Cancer Genetics Corporate Information, Head Office, and Major Competitors
Table 23. Cancer Genetics Major Business
Table 24. Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Product and Solutions
Table 25. Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Castle Biosciences Corporate Information, Head Office, and Major Competitors
Table 27. Castle Biosciences Major Business
Table 28. Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Product and Solutions
Table 29. Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. NeoGenomics Corporate Information, Head Office, and Major Competitors
Table 31. NeoGenomics Major Business
Table 32. NeoGenomics Melanoma Skin Cancer Diagnostic Testing Product and Solutions
Table 33. NeoGenomics Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Dermtech Corporate Information, Head Office, and Major Competitors
Table 35. Dermtech Major Business
Table 36. Dermtech Melanoma Skin Cancer Diagnostic Testing Product and Solutions
Table 37. Dermtech Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Sysmex Inostics Corporate Information, Head Office, and Major Competitors
Table 39. Sysmex Inostics Major Business
Table 40. Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Product and Solutions
Table 41. Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Global Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 43. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 44. Breakdown of Melanoma Skin Cancer Diagnostic Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Melanoma Skin Cancer Diagnostic Testing Players Head Office, Products and Services Provided
Table 46. Melanoma Skin Cancer Diagnostic Testing Mergers & Acquisitions in the Past Five Years
Table 47. Melanoma Skin Cancer Diagnostic Testing New Entrants and Expansion Plans
Table 48. Global Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million) by Type (2017-2022)
Table 49. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Type (2017-2022)
Table 50. Global Melanoma Skin Cancer Diagnostic Testing Revenue Forecast by Type (2023-2028)
Table 51. Global Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2022)
Table 52. Global Melanoma Skin Cancer Diagnostic Testing Revenue Forecast by Application (2023-2028)
Table 53. North America Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2022) & (USD Million)
Table 54. North America Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2023-2028) & (USD Million)
Table 55. North America Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2022) & (USD Million)
Table 56. North America Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2023-2028) & (USD Million)
Table 57. North America Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2017-2022) & (USD Million)
Table 58. North America Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2023-2028) & (USD Million)
Table 59. Europe Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2022) & (USD Million)
Table 60. Europe Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2023-2028) & (USD Million)
Table 61. Europe Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2022) & (USD Million)
Table 62. Europe Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2023-2028) & (USD Million)
Table 63. Europe Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2017-2022) & (USD Million)
Table 64. Europe Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2023-2028) & (USD Million)
Table 65. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2022) & (USD Million)
Table 66. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2023-2028) & (USD Million)
Table 67. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2022) & (USD Million)
Table 68. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2023-2028) & (USD Million)
Table 69. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue by Region (2017-2022) & (USD Million)
Table 70. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue by Region (2023-2028) & (USD Million)
Table 71. South America Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2022) & (USD Million)
Table 72. South America Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2023-2028) & (USD Million)
Table 73. South America Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2022) & (USD Million)
Table 74. South America Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2023-2028) & (USD Million)
Table 75. South America Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2017-2022) & (USD Million)
Table 76. South America Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2023-2028) & (USD Million)
Table 77. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2022) & (USD Million)
Table 78. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2023-2028) & (USD Million)
Table 79. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2022) & (USD Million)
Table 80. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2023-2028) & (USD Million)
Table 81. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2017-2022) & (USD Million)
Table 82. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2023-2028) & (USD Million)
Table 1. Global Melanoma Skin Cancer Diagnostic Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Melanoma Skin Cancer Diagnostic Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Melanoma Skin Cancer Diagnostic Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Region (2023-2028)
Table 6. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 7. Myriad Genetics Major Business
Table 8. Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Product and Solutions
Table 9. Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Product and Solutions
Table 13. Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Foundation Medicine Corporate Information, Head Office, and Major Competitors
Table 15. Foundation Medicine Major Business
Table 16. Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Product and Solutions
Table 17. Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Pathway Genomics Corporation Corporate Information, Head Office, and Major Competitors
Table 19. Pathway Genomics Corporation Major Business
Table 20. Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Product and Solutions
Table 21. Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Cancer Genetics Corporate Information, Head Office, and Major Competitors
Table 23. Cancer Genetics Major Business
Table 24. Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Product and Solutions
Table 25. Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Castle Biosciences Corporate Information, Head Office, and Major Competitors
Table 27. Castle Biosciences Major Business
Table 28. Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Product and Solutions
Table 29. Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. NeoGenomics Corporate Information, Head Office, and Major Competitors
Table 31. NeoGenomics Major Business
Table 32. NeoGenomics Melanoma Skin Cancer Diagnostic Testing Product and Solutions
Table 33. NeoGenomics Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Dermtech Corporate Information, Head Office, and Major Competitors
Table 35. Dermtech Major Business
Table 36. Dermtech Melanoma Skin Cancer Diagnostic Testing Product and Solutions
Table 37. Dermtech Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Sysmex Inostics Corporate Information, Head Office, and Major Competitors
Table 39. Sysmex Inostics Major Business
Table 40. Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Product and Solutions
Table 41. Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Global Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 43. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 44. Breakdown of Melanoma Skin Cancer Diagnostic Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Melanoma Skin Cancer Diagnostic Testing Players Head Office, Products and Services Provided
Table 46. Melanoma Skin Cancer Diagnostic Testing Mergers & Acquisitions in the Past Five Years
Table 47. Melanoma Skin Cancer Diagnostic Testing New Entrants and Expansion Plans
Table 48. Global Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million) by Type (2017-2022)
Table 49. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Type (2017-2022)
Table 50. Global Melanoma Skin Cancer Diagnostic Testing Revenue Forecast by Type (2023-2028)
Table 51. Global Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2022)
Table 52. Global Melanoma Skin Cancer Diagnostic Testing Revenue Forecast by Application (2023-2028)
Table 53. North America Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2022) & (USD Million)
Table 54. North America Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2023-2028) & (USD Million)
Table 55. North America Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2022) & (USD Million)
Table 56. North America Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2023-2028) & (USD Million)
Table 57. North America Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2017-2022) & (USD Million)
Table 58. North America Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2023-2028) & (USD Million)
Table 59. Europe Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2022) & (USD Million)
Table 60. Europe Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2023-2028) & (USD Million)
Table 61. Europe Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2022) & (USD Million)
Table 62. Europe Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2023-2028) & (USD Million)
Table 63. Europe Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2017-2022) & (USD Million)
Table 64. Europe Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2023-2028) & (USD Million)
Table 65. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2022) & (USD Million)
Table 66. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2023-2028) & (USD Million)
Table 67. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2022) & (USD Million)
Table 68. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2023-2028) & (USD Million)
Table 69. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue by Region (2017-2022) & (USD Million)
Table 70. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue by Region (2023-2028) & (USD Million)
Table 71. South America Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2022) & (USD Million)
Table 72. South America Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2023-2028) & (USD Million)
Table 73. South America Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2022) & (USD Million)
Table 74. South America Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2023-2028) & (USD Million)
Table 75. South America Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2017-2022) & (USD Million)
Table 76. South America Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2023-2028) & (USD Million)
Table 77. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2017-2022) & (USD Million)
Table 78. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue by Type (2023-2028) & (USD Million)
Table 79. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2017-2022) & (USD Million)
Table 80. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue by Application (2023-2028) & (USD Million)
Table 81. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2017-2022) & (USD Million)
Table 82. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. Melanoma Skin Cancer Diagnostic Testing Picture
Figure 2. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Type in 2021
Figure 3. Biopsy
Figure 4. Imaging
Figure 5. Others
Figure 6. Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Application in 2021
Figure 7. Hospitals Picture
Figure 8. Dermatology Clinics Picture
Figure 9. Diagnostic Laboratories Picture
Figure 10. Others Picture
Figure 11. Global Melanoma Skin Cancer Diagnostic Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Melanoma Skin Cancer Diagnostic Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Region (2017-2028)
Figure 14. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Region in 2021
Figure 15. North America Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Melanoma Skin Cancer Diagnostic Testing Market Drivers
Figure 21. Melanoma Skin Cancer Diagnostic Testing Market Restraints
Figure 22. Melanoma Skin Cancer Diagnostic Testing Market Trends
Figure 23. Myriad Genetics Recent Developments and Future Plans
Figure 24. Abbott Laboratories Recent Developments and Future Plans
Figure 25. Foundation Medicine Recent Developments and Future Plans
Figure 26. Pathway Genomics Corporation Recent Developments and Future Plans
Figure 27. Cancer Genetics Recent Developments and Future Plans
Figure 28. Castle Biosciences Recent Developments and Future Plans
Figure 29. NeoGenomics Recent Developments and Future Plans
Figure 30. Dermtech Recent Developments and Future Plans
Figure 31. Sysmex Inostics Recent Developments and Future Plans
Figure 32. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Players in 2021
Figure 33. Melanoma Skin Cancer Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 34. Global Top 3 Players Melanoma Skin Cancer Diagnostic Testing Revenue Market Share in 2021
Figure 35. Global Top 10 Players Melanoma Skin Cancer Diagnostic Testing Revenue Market Share in 2021
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 37. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Type in 2021
Figure 38. Global Melanoma Skin Cancer Diagnostic Testing Market Share Forecast by Type (2023-2028)
Figure 39. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Application in 2021
Figure 40. Global Melanoma Skin Cancer Diagnostic Testing Market Share Forecast by Application (2023-2028)
Figure 41. North America Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Type (2017-2028)
Figure 42. North America Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Application (2017-2028)
Figure 43. North America Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Country (2017-2028)
Figure 44. United States Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Type (2017-2028)
Figure 48. Europe Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Application (2017-2028)
Figure 49. Europe Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Country (2017-2028)
Figure 50. Germany Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Type (2017-2028)
Figure 56. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Region (2017-2028)
Figure 58. China Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South Korea Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Type (2017-2028)
Figure 65. South America Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Application (2017-2028)
Figure 66. South America Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East and Africa Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Application (2017-2028)
Figure 71. Middle East and Africa Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Country (2017-2028)
Figure 72. Turkey Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. UAE Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
Figure 1. Melanoma Skin Cancer Diagnostic Testing Picture
Figure 2. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Type in 2021
Figure 3. Biopsy
Figure 4. Imaging
Figure 5. Others
Figure 6. Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Application in 2021
Figure 7. Hospitals Picture
Figure 8. Dermatology Clinics Picture
Figure 9. Diagnostic Laboratories Picture
Figure 10. Others Picture
Figure 11. Global Melanoma Skin Cancer Diagnostic Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Melanoma Skin Cancer Diagnostic Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Region (2017-2028)
Figure 14. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Region in 2021
Figure 15. North America Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Melanoma Skin Cancer Diagnostic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Melanoma Skin Cancer Diagnostic Testing Market Drivers
Figure 21. Melanoma Skin Cancer Diagnostic Testing Market Restraints
Figure 22. Melanoma Skin Cancer Diagnostic Testing Market Trends
Figure 23. Myriad Genetics Recent Developments and Future Plans
Figure 24. Abbott Laboratories Recent Developments and Future Plans
Figure 25. Foundation Medicine Recent Developments and Future Plans
Figure 26. Pathway Genomics Corporation Recent Developments and Future Plans
Figure 27. Cancer Genetics Recent Developments and Future Plans
Figure 28. Castle Biosciences Recent Developments and Future Plans
Figure 29. NeoGenomics Recent Developments and Future Plans
Figure 30. Dermtech Recent Developments and Future Plans
Figure 31. Sysmex Inostics Recent Developments and Future Plans
Figure 32. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Players in 2021
Figure 33. Melanoma Skin Cancer Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 34. Global Top 3 Players Melanoma Skin Cancer Diagnostic Testing Revenue Market Share in 2021
Figure 35. Global Top 10 Players Melanoma Skin Cancer Diagnostic Testing Revenue Market Share in 2021
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 37. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Type in 2021
Figure 38. Global Melanoma Skin Cancer Diagnostic Testing Market Share Forecast by Type (2023-2028)
Figure 39. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Application in 2021
Figure 40. Global Melanoma Skin Cancer Diagnostic Testing Market Share Forecast by Application (2023-2028)
Figure 41. North America Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Type (2017-2028)
Figure 42. North America Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Application (2017-2028)
Figure 43. North America Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Country (2017-2028)
Figure 44. United States Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Type (2017-2028)
Figure 48. Europe Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Application (2017-2028)
Figure 49. Europe Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Country (2017-2028)
Figure 50. Germany Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Type (2017-2028)
Figure 56. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Region (2017-2028)
Figure 58. China Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South Korea Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Type (2017-2028)
Figure 65. South America Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Application (2017-2028)
Figure 66. South America Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East and Africa Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa Melanoma Skin Cancer Diagnostic Testing Sales Market Share by Application (2017-2028)
Figure 71. Middle East and Africa Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Country (2017-2028)
Figure 72. Turkey Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. UAE Melanoma Skin Cancer Diagnostic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
